Dan Hart

Dan Hart

Company: Epic Bio

Job title: Head of Technology Development

Bio:

Daniel Hart, Ph.D., is Head of Technology Development at Epicrispr Bio. Dr. Hart completed postdoctoral training in the laboratory of Michael R. Green at the University of Massachusetts, and he was an assistant professor in the Cardiovascular Research Institute at University of California, San Francisco. Dr. Hart’s laboratory used genome engineering approaches, including CRISPR and CRISPRa/i, to study gene regulatory networks in vertebrate cardiovascular development.

Seminars:

GEMS: A CRISPR Epigenetics Platform to Revolutionise Genetic Medicine 1:30 pm

Enabling in vivo gene therapy with a hypercompact platform, dCas proteins, epigenetic modulators, and guides Durable gene suppression and activation after transient GEMS expression A de-risked platform for in vivo gene therapy: FSHDRead more

day: Day 1 Track A PM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.